Skip to main navigation Skip to search Skip to main content

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

  • The CONSIT TEAM study
  • National Institutes of Health
  • Program in Cancer Prevention and Population Research
  • Mayo Clinic
  • Harvard University
  • Massachusetts General Hospital
  • Cornell University
  • American Cancer Society
  • University of Cambridge
  • Queensland Institute of Medical Research
  • Centre de Recherche en Cancérologie de Lyon
  • Université de Lyon
  • Roswell Park Cancer Institute
  • NorthShore University HealthSystem
  • Netherlands Cancer Institute
  • Erasmus University Rotterdam
  • Radboud University Nijmegen
  • Leiden University
  • VU University Medical Center
  • Maastricht University
  • Hospital Clínico San Carlos de Madrid
  • Pomeranian Medical University in Szczecin
  • Maria Sklodowska-Curie Institute of Oncology
  • Helsinki University Hospital
  • Institute Catala Oncologia
  • Landspitali University Hospital
  • University of Iceland
  • IRCCS Istituto Oncologico Veneto - Padova
  • University of Padua
  • University of Chicago
  • City of Hope National Medical Center
  • Fondazione IRCCS Istituto Nazionale dei Tumori
  • IRCCS Istituto Europeo di Oncologia - Milano
  • FIRC Institute of Molecular Oncology
  • University of Vienna
  • Clalit Health Services
  • University of Toronto
  • Ohio State University
  • University of Pisa
  • University of California at San Francisco
  • University of Pennsylvania
  • University of South Florida
  • Cancer Prevention Institute of California
  • University of Melbourne
  • University of Utah
  • Columbia University
  • Beth Israel Deaconess Medical Center
  • University of Copenhagen
  • Biomedical Network on Rare Diseases (CIBERER)
  • Center for Biomedical Network Research on Rare Diseases (CIBERER)
  • Human Cancer Genetics Programme
  • Institute of Biology and Molecular Genetics. Universidad de Valladolid (IBGM-UVA)
  • German Cancer Research Center
  • Manchester University NHS Foundation Trust
  • Royal Marsden Hospital
  • Guy's and St Thomas' NHS Foundation Trust
  • Cambridge University Hospitals NHS Foundation Trust
  • Royal Devon & Exeter NHS Foundation Trust
  • St. Georges Hospital
  • Belfast Health and Social Care Trust
  • Western General Hospital
  • Oxford University Hospitals NHS Foundation Trust
  • University Hospital of Wales
  • Great Ormond Street Hospital for Children NHS Foundation Trust
  • University of Kansas
  • University of Cologne
  • The Gertner Institute
  • Technical University of Munich
  • Ulm University
  • Charité – Universitätsmedizin Berlin
  • University of Münster
  • Technische Universität Dresden
  • Centre Hospitalier Universitaire Dupuytren
  • Institut national de la santé et de la recherche médicale

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

Three founder mutations in BRCA1 and BRCA2 contribute to the risk of hereditary breast and ovarian cancer in Ashkenazi Jews (AJ). They are observed at increased frequency in the AJ compared to other BRCA mutations in Caucasian non-Jews (CNJ). Several authors have proposed that elevated allele frequencies in the surrounding genomic regions reflect adaptive or balancing selection. Such proposals predict long-range linkage disequilibrium (LD) resulting from a selective sweep, although genetic drift in a founder population may also act to create long-distance LD. To date, few studies have used the tools of statistical genomics to examine the likelihood of long-range LD at a deleterious locus in a population that faced a genetic bottleneck. We studied the genotypes of hundreds of women from a large international consortium of BRCA1 and BRCA2 mutation carriers and found that AJ women exhibited long-range haplotypes compared to CNJ women. More than 50% of the AJ chromosomes with the BRCA1 185delAG mutation share an identical 2.1 Mb haplotype and nearly 16% of AJ chromosomes carrying the BRCA2 6174delT mutation share a 1.4 Mb haplotype. Simulations based on the best inference of Ashkenazi population demography indicate that long-range haplotypes are expected in the context of a genome-wide survey. Our results are consistent with the hypothesis that a local bottleneck effect from population size constriction events could by chance have resulted in the large haplotype blocks observed at high frequency in the BRCA1 and BRCA2 regions of Ashkenazi Jews.

Original languageEnglish
Pages (from-to)685-699
Number of pages15
JournalHuman Genetics
Volume130
Issue number5
DOIs
StatePublished - Nov 1 2011

Keywords

  • Arthritis/genetics
  • BRCA1 Protein/genetics
  • BRCA2 Protein/genetics
  • Base Sequence
  • Computer Simulation
  • Deafness/genetics
  • Female
  • Founder Effect
  • Genotype
  • Haplotypes/genetics
  • Heterozygote
  • Humans
  • Jews/genetics
  • Polychondritis, Relapsing/genetics
  • Sequence Deletion

Fingerprint

Dive into the research topics of 'Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers'. Together they form a unique fingerprint.

Cite this